Autonomix Medical (AMIX): Volume dana dhuwit perusahaan

Simbol resmi perusahaan Autonomix Medical (AMIX)

The cash reserve dynamics clearly demonstrate asset liquidity, while 0.01 captures the current state of the parameter. A lack of profit coupled with constant expenditures on catheter development renders the cash flow unstable. Pressure from corporate behemoths in the neuromonitoring niche limits access to government procurement. Autonomix Medical, Inc. (AMIX) is currently focusing on clinical trials for cancer pain therapy platforms and FDA certification.

Dana dhuwit perusahaan: Autonomix Medical (AMIX) kanggo 21.02.2024 - 21.11.2026

Ringkesan rincian data analitis autonomix.com (AMIX)

Analisis wiwitan perusahaan:Autonomix Medical Inc. AMIX
Produk merek Autonomix Medical, Inc.

For the long-term investor, a key reliability criterion for Autonomix Medical, Inc. (AMIX) is the company's ability to maintain operations without external borrowing. This metric measures the total liquid assets available for the immediate settlement of liabilities and the financing of growth. By analyzing the volume of physical cash, one can assess the business's margin of safety. Amid chip supply disruptions and trade restrictions, this reserve is critical for diversifying logistics. A stable liquidity level confirms the company's resilience to geopolitical shocks.

Analisis perusahaan pesaing

Volume dana dhuwit perusahaan BSX|Dana dhuwit perusahaan EW (Edwards Lifesciences Corporation)|Dana dhuwit perusahaan ResMed RMD|Volume dana dhuwit perusahaan Insulet Corp PODD|ZBH: Dhuwit awis perusahaan|Sisa dhuwit perusahaan COO (CooperVision)|ALGN (Align Technology, Inc.) - Dhuwit awis perusahaan|Globus Medical, Inc. - Sisa dhuwit perusahaan|TMDX (TransMedics Group Inc) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alphatec Holdings ATEC|Dana dhuwit perusahaan CryoLife (AORT)|Enovis Corporation (ENOV) - Posisi dhuwit perusahaan|Integra LifeSciences Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Establishment Labs ESTA|Beta Bionics, Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan IRADIMED Corp IRMD|Embecta (EMBC) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan TNDM (Tandem Corp)|Dana dhuwit perusahaan axogeninc.com|Dhuwit awis perusahaan SI-BONE, Inc. (SIBN)|Volume dana dhuwit perusahaan OFIX|Bioventus Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan orthopediatrics.com KIDS|TMCI: Dhuwit awis lan setara dhuwit awis perusahaan|SRTA: Dhuwit awis perusahaan|Carlsmed Inc - Gunggung dana dhuwit perusahaan|RxSight (RXST) - Dana dhuwit perusahaan|Dhuwit awis perusahaan ClearPoint|Dhuwit awis perusahaan STXS|Cadangan dhuwit perusahaan Neuronetics, Inc. STIM|Volume dana dhuwit perusahaan SGHT|Dhuwit awis perusahaan Orchestra BioMed OBIO|Dana dhuwit perusahaan Anika Therapeutics Inc. ANIK|NSPR (InspireMD) - Total volume dana dhuwit perusahaan|ZJYL - Dana dhuwit perusahaan|VANI (vivani.com) - Dhuwit awis lan setara dhuwit awis perusahaan|XTNT (Xtant Medical Inc) - Dhuwit awis perusahaan|Cadangan dhuwit perusahaan n1mtc.com (NMTC)|Dana dhuwit perusahaan modular-medical.com|Dhuwit awis lan setara dhuwit awis perusahaan MYO (Myomo)|Volume dana dhuwit perusahaan COCH|VVOS (Vivos Therapeutics, Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan envveno.com NVNO|SINT - Dhuwit awis perusahaan|Tenon Medical Inc. - Volume dana dhuwit perusahaan|LFWD: Dana dhuwit perusahaan|IVF: Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan Bone Biologics Corporation BBLG|Dhuwit awis perusahaan AXNX|BIOLASE, Inc. (BIOL) - Aset likuid perusahaan|Volume dana dhuwit perusahaan DYNT|Aset likuid perusahaan Paragon 28|Volume dana dhuwit perusahaan INVO (INVO Bioscience, Inc.)